Skip to main content
SpringerLink
Log in

High-dose intravenous corticosteroid therapy for Graves’ ophthalmopathy

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

In order to compare oral and high-dose iv corticosteroid therapy for Graves’ disease, 25 patients with Graves’ ophthalmopathy were treated with two weekly iv injections of 1g of methylprednisolone diluted in 250–500 ml of physiological solution for 6 weeks, and were compared to a group of 26 patients treated with oral prednisone at a dose of 60–80 mg/day progressively reduced every 2 weeks for a total duration of 4–6 months. The efficacy of treatment was evaluated using the ophthalmopathy index score. Patients were followed at 3, 6, 12 months, and afterwards yearly. All patients showed a significant improvement in signs and symptoms of orbital inflammation and a slight improvement in proptosis and diplopia. Relevant side-effects were reported from patients receiving oral therapy, but no significant side-effects were observed in patients treated with high iv doses; a few cases presented with gastric pain (highly sensitive to aluminium oxide or ranitidine), while most of the patients referred to cutaneous rashes and a metal taste that disappeared some hours after the infusion. Improvements observed after treatment have been stable in both groups. In conclusion, in addition to a lower incidence of side-effects compared to the classic oral therapy, the high-dose iv steroid therapy provides efficient and stable improvement in Graves’ ophthalmopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Werner S., Coleman D.J., Franzen L.A. Ultrasonic evidence of a consistent orbital involvement in Graves’ disease. N. Engl. J. Med. 1974, 28: 1447–1450.

    Article  Google Scholar 

  2. Forbes G., Gorman C.A., Brennan M.D., Gehring D.G., Ilstrup D.M., Earnest F. Ophtalmopathy of Graves’ disease: computerized volume measurement of the orbital fat and muscle. Am. J. Neuroradiol. 1986, 7: 651–656.

    CAS  PubMed  Google Scholar 

  3. Perros P., Kendall-Taylor P. Biological activity of autoantibodies from patients with thyroid-associated ophtalmopathy: in vitro effects on porcine extraocular myoblasts. Q. J. Med. 1992, 305: 691–706.

    Article  Google Scholar 

  4. Bahn R.S., Gorman C.A., Woloschak G.E., David C.S., Johnson P.H., Johnson C.M. Human retroocular fibroblast in vitro: a model for the study of Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 1987, 65: 665–670.

    Article  CAS  PubMed  Google Scholar 

  5. Kodama K., Sikorska H., Brandy-Dafoe P., Bayly R., Wall J.R. Demostrating of a circulating autoantibody against a soluble eye muscle antigen in Graves’ ophthalmopathy. Lancet 1982, 2: 1353–1356.

    Article  CAS  PubMed  Google Scholar 

  6. Salvi M., Miller A., Wall J.R. Human orbital tissue and thyroid membranes express a 64 KDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett. 1988, 232: 135–139.

    Article  CAS  PubMed  Google Scholar 

  7. Feliciello A., Porcellini A., Ciullo I.G.B., Avvedimento E., Fenzi G. Expression of thyrotropin-receptor mRNA in healthy and Graves’ disease retro-orbital tissue. Lancet 1993, 342: 337–338.

    Article  CAS  PubMed  Google Scholar 

  8. Paschke R., Metcalfe A., Alcalde L., Vassart G., Weetman A., Ludgate M. Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues. J. Clin. Endocrinol. Metab. 1994, 79: 1234–1238.

    CAS  PubMed  Google Scholar 

  9. Mengistu M., Lukes Y.G., Nagy E.V., Burch H.B., Carr F.E., Lahiri S., Burman K.D. TSH receptor gene expression in retroocular fibroblasts. J. Endocrinol. Invest. 1994, 17: 437–441.

    CAS  PubMed  Google Scholar 

  10. Bartalena L., Marcocci C., Chiovato L., Laddaga M., Lepri G., Andreani D., Cavallacci G., Baschieri L., Pinchera A. Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophtalmopathy: comparison with systemic corticosteroids alone. J. Clin. Endocrinol. Metab. 1983, 56: 1139–1144.

    Article  CAS  PubMed  Google Scholar 

  11. Weissel M., Zielinski C., Hauff W., Till P. Combined therapy with cyclosporin A and cortisone in endocrine Basedow endocrine orbitopathy: successful use in compressive optic neuropathy. Acta Med. Austriaca 1993, 20: 9–13.

    CAS  PubMed  Google Scholar 

  12. Burch H.B., Wartofsk Y.L. Graves’ ophthalmopathy: current concepts regarding pathogenesis and management. Endocr. Rev. 1993, 14: 747–793.

    CAS  PubMed  Google Scholar 

  13. Antonelli A., Saracino A., Alberti B., Canapicchi R., Cartei F., Lepri A., Laddaga M., Baschieri L. High-dose intravenous immunoglobulin treatment in Graves’ ophthalmopathy. Acta Endocrinol. (Copenh.) 1992, 126: 13–23.

    CAS  Google Scholar 

  14. Bartalena L., Marocci C., Bogazzi F., Bruno-Bossio G., Pinchera A. Glucocorticoid therapy of Graves’ ophthalmopathy. Exp. Clin. Endocrinol. 1991, 97: 320–327.

    Article  CAS  PubMed  Google Scholar 

  15. Bartalena L., Pinchera A., Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr. Rev. 2000, 21: 168–194.

    CAS  PubMed  Google Scholar 

  16. American Thyroid Association Classification of eye changes of Graves’ disease. Thyroid 1992, 2: 235–236.

    Article  Google Scholar 

  17. Grubbs F. Procedures for detecting outlying observations in samples. Technometrics 1969, 11: 1–21.

    Article  Google Scholar 

  18. Grubbs F.E., Beck G. Extension of sample sizes and percentage points for signficance tests of outlying observations. Technometrics 1972, 14: 847–854.

    Article  Google Scholar 

  19. Nagayama Y., Izumi M., Kiriyame T., Yokoyama N., Morita S., Kakezono F., Ohtakara S. Treatment of Graves’ ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy. Acta Endocrinol. (Copenh.) 1987, 116: 513–518.

    CAS  Google Scholar 

  20. Kendall-Taylor P., Crombie A.L., Stephenson A.M.M.H., Hall K. Intravenous methylprednisolone in the treatment of Graves’ ophthalmopathy. B.M.J. 1988, 297: 1574–1578.

    Article  CAS  Google Scholar 

  21. Bromberg N., Romaldini J.H., Sgarbi J.A., Werner R.S., Farah C.S., Figuerido D.I., Laudari H., Werner M.C. Pulse therapy in Graves’ ophthalmopathy: improvement of eye signs and ophtalmic immunoglobulins. In: Gordon A., Gross J., Hennemann G. (Eds.), Progress in thyroid research. A.A. Balkema Publisher, The Hague, 1991, p. 353.

    Google Scholar 

  22. Romaldini J.H., Werner R.S., Farah C.S., Figuerido D.I., Tanaka-Matsura L., Bromberg N. Active Graves’ ophthalmopathy (GO) treatment with prolonged methylprednisolone therapy. Thyroid 1993, 3 (Suppl.): T2.

    Google Scholar 

  23. Hiromatsu Y., Tanaka K., Sato M., Kuroki T., Nonaka K., Kojima K., Nishimura H., Nishida H., Kaise N. Intravenous methylprednisolone pulse therapy for Graves’ ophthalmopathy. J. Endocr. 1993, 40: 63–72.

    Article  CAS  Google Scholar 

  24. Koshiyama H., Koh T., Fujiwara K., Hayakawa K., Shimbo S., Misaki T. Therapy of Graves’ ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation. Thyroid 1994, 4: 409–413.

    Article  CAS  PubMed  Google Scholar 

  25. Özmen B., Erkin E., Saruç M. The efficacy of high dose pulse steroid (methylprednisolone) therapy in Graves’ ophthalmopathy. Turkish J. Endocrinol. Metab. 1998, 3: 185–189.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Università degli Studi di Napoli “Federico II”, Via S. Pansini 5, 80131, Napoli, Italy

    P. E. Macchia, M. Bagattini, G. Lupoli, M. Vitale, G. Vitale &  G. Fenzi (Chair of Endocrinology)

Authors
  1. P. E. Macchia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bagattini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Lupoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Fenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Fenzi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Macchia, P.E., Bagattini, M., Lupoli, G. et al. High-dose intravenous corticosteroid therapy for Graves’ ophthalmopathy. J Endocrinol Invest 24, 152–158 (2001). https://doi.org/10.1007/BF03343835

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343835

Key-words

Search

Navigation